You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 2, February 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intraocular Pressure Effects of Multiple Doses of Drugs Applied to Glaucomatous Monkey Eyes

Ping-Yu Lee, MD; Steven M. Podos, MD; Janet B. Serle, MD; Carl B. Camras, MD; Colette H. Severin, MS

Arch Ophthalmol. 1987;105(2):249-252.


Abstract

• The effects of multiple dosing with 0.5% timolol maleate, 2% epinephrine hydrochloride, 4% pilocarpine hydrochloride, 1% vanadate, 1% forskolin (nonproprietary name, colforsin), or 0.5% prostaglandin F2{alpha} on intraocular pressure (IOP) were each tested on eight cynomolgus monkey eyes in which glaucoma was induced by photocoagulating the trabecular meshwork with the argon laser. The week prior to drug therapy, baseline IOP measurements were carried out at hourly intervals from 9:30 AM to 3:30 PM on three days. One to two days later, therapy was initiated. Each drug was applied topically to both eyes of each monkey twice daily for at least four days. The IOP was measured with a calibrated pneumatonometer at the same hourly intervals on treatment days as on the baseline days. The IOP at each time of day on treatment days was compared with the average baseline IOP measured at the corresponding time of day. Topical application of timolol, epinephrine, pilocarpine, vanadate, and prostaglandin F2{alpha} significantly reduced IOP without evidence of tolerance or tachyphylaxis during the course of therapy. Forskolin did not significantly decrease IOP after the second day of treatment.



Author Affiliations

From the Department of Ophthalmology, Mount Sinai School of Medicine, 1 Gustave L. Levy PI, New York.


Footnotes

Accepted for publication July 7, 1986.

Reprint requests to Department of Ophthalmology, Mount Sinai School of Medicine, 1 Gustave L. Levy PI, New York, NY 10029 (Dr Podos).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Prostanoid EP2 Receptor Agonist Butaprost Increases Uveoscleral Outflow in the Cynomolgus Monkey.
Nilsson et al.
IOVS 2006;47:4042-4049.
ABSTRACT | FULL TEXT  

Effect of Ticrynafen on Aqueous Humor Dynamics in Monkeys
Croft et al.
Arch Ophthalmol 1998;116:1481-1488.
ABSTRACT | FULL TEXT  

The Ocular Hypotensive Effect of the Topical Carbonic Anhydrase Inhibitor L-671,152 in Glaucomatous Monkeys
Wang et al.
Arch Ophthalmol 1990;108:511-513.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.